Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-01-08

FDA Approved: RIVASTIGMINE — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved Amneal Pharmaceuticals' generic rivastigmine via Original Application (ANDA). The product is indicated for the treatment of cognitive symptoms …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivastigmine (Rivastigmine)

Snippet

ORIG AP for RIVASTIGMINE (RIVASTIGMINE)